ELICIR announces the granting of a second US patent covering the biocontrol performance of its plant extract.

ELICIR's biocontrol technology has been recognized as a patentable invention by the highly demanding US Patent Office. This development completes ELICIR's portfolio of titles. A previous US patent on biostimulation functionality is included.

Obtaining this new "Biocontrol" patent in the United States is a major step in the development of ELICIR's intellectual property. The US patent office is very demanding... and intellectual property is highly respected in this major market. For ELICIR, which is presenting its breakthrough innovation with unprecedented and unrivalled efficacy on diseases which have reached a technological impasse(Xyllela fastidiosa on olive trees, beet yellows virus...), but also on diseases which have existing chemical or mineral solutions (powdery mildew, downy mildew, bacterial blight on walnut trees...), this recognition will enable it to extend its field of intervention and partnerships. It follows our European certifications (EC regulation 2019-1009) as non-microbial Biostimulants - plant extracts for ARCOLAN and MIGAS on all crops.